Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-001862
Filing Date
2025-03-14
Accepted
2025-03-14 16:21:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3361
  Complete submission text file 0001950047-25-001862.txt   4790
Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 203 CRESCENT STREET, BLDG. 17, SUITE 102 WALTHAM MA 02453
Business Address
Meisner Lara (Reporting) CIK: 0001883986 (see all company filings)

Type: 144

Mailing Address 245 MAIN STREET CAMBRIDGE MA 02142
Business Address 245 MAIN STREET CAMBRIDGE MA 02142 617-785-8308
Bicara Therapeutics Inc. (Subject) CIK: 0002023658 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-42271 | Film No.: 25740295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)